David Einspahr is an expert in the field of Hematology. He went to medical school at University of Kansas School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". David Einspahr is a published doctor. He published 2 publications, including: 'Specific binding of acidic isoferritins to erythroleukemia K562 cells.' He is registered with Medicare.
NPI NUMBER | 1780634923 | |
NPPES Provider LastName | EINSPAHR | |
NPPES Provider FirstName | DAVID | |
NPPES Provider ZIPCode | 666061535 | |
NPPES Provider State | KS | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 1337.0 | |
Distinct Opioid Count | 6.0 | |
Opioid Claim Count | 155.0 | |
Percent Opioid Claims | 11.59 |
National Provider Identifier [NPI] | 1780634923 |
Last Name Of The Provider | EINSPAHR |
First Name Of The Provider | DAVID |
View All |
![]() |
Dr. Karissa W. Boyd, DO
![]() |
![]() |
Dr. Mark L. Pudwill, MD
![]() |
![]() |
Dr. Edwin L. Petrik, MD
![]() |
![]() |
Dr. Howard N. Ward, MD
![]() |
![]() |
Dr. Stanley J. Vogel, MD
![]() |
![]() |
Dr. Adrian A. Caracioni, MD
![]() ![]() |
![]() |
Dr. Michael A. Hurwitz, MD
![]() |
![]() |
Dr. Mouhammed J. Kyasa, MD
![]() ![]() |